CDKN2AIP has been shown to interact with ARF, which activates the key tumor suppressor gene p53 by ARF-dependent or independent pathways, causing inhibition of tumor growth and tumor cell senescence [7,8]. Here, CDKN2AIP is linked to neoplasm.